New drug aims to strengthen bones by cutting body acid
NCT ID NCT07473713
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called veverimer in 60 adults aged 50 and older with osteopenia (low bone density). The goal is to see if lowering acid levels in the body can reduce bone breakdown. Participants take the drug or a placebo daily or every other day for 8 weeks, with 8 clinic visits for monitoring. The study focuses on safety and finding the right dose.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tufts Medical Center
RECRUITINGBoston, Massachusetts, 02111, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A tastier calcium chew might boost bone Health—But does it work?
- Light on bones: laser therapy may boost bone health in postmenopausal women
- Heavy weights vs. light weights: which builds better bones?
- Could a simple exercise program strengthen bones without drugs?
- New index could reveal hidden Muscle-Bone imbalances
- No-Radiation bone scan could spot fracture risk early